Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial

Clinical trial NCT05161533 · WITHDRAWN

Trial details

NCT number: NCT05161533
Sponsor: University of Washington
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Lung Small Cell Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8

Start date: 2023-10-19
Primary completion: 2024-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.